ロード中...
Depth of remission is a prognostic factor for survival in patients with metastatic renal cell carcinoma
BACKGROUND: Response remains an important endpoint in clinical cancer trials. However, the prognostic utility of best tumor response in metastatic renal cell carcinoma (mRCC) remains vague. OBJECTIVE: To define the prognostic relevance of the depth of remission in mRCC DESIGN, SETTING, AND PARTICIPA...
保存先:
| 出版年: | Eur Urol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4570832/ https://ncbi.nlm.nih.gov/pubmed/25577718 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2014.12.036 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|